»
Antikörper
»
anti-Serologically Defined Breast Cancer Antigen NY-BR-24 (SEPT1) Antikörper
Serologically Defined Breast Cancer Antigen NY-BR-24 (SEPT1) Antikörper
| Antigen |
|
| Synonyme |
LARP, SEP1, DIFF6, PNUTL3, MGC20394 |
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Applikation
|
ELISA
|
| Produktnummer |
ABIN185707 |
| Menge |
100 ug |
| Preis |
226,00 € Zzgl. Versandkosten €40,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 Werktagen |
|
Weitere Bezeichnung
|
Septin 1 / SEPT1
|
|
Gen-ID
|
1731, 54204 (mouse), 293507 (rat)
|
|
Immunogen
|
C-GARDRASRSKLSRQ
|
|
Format
|
Affinity-purified
|
|
Beschreibung
|
All names and symbols: SEPT1, septin 1 , DIFF6, LARP, MGC20394, PNUTL3, SEP1 , differentiation 6 (deoxyguanosine triphosphate triphosphohydrolase), serologically defined breast cancer antigen NY-BR-24. Official Symbol: 01.09.01. RefSeq number(s): NP_443070.1
|
|
Spezifität
|
Human, Mouse, Rat, Dog 367 aa
|
|
Applikationshinweise
|
Peptide ELISA: antibody detection limit dilution 1:32,000. Western Blot: Preliminary experiments gave an approx 30kDa band in Mouse and Rat Brain lysates after 1µg/ml antibody staining. Please note that currently we cannot find an explanation in the literature for the band we observe given the calculated size of 42.0 kDa according to mouse NP_059489.1. The 30kDa band was successfully blocked by incubation with the immunizing peptide. We would appreciate any feedback from people in the field - have any results been reported with other antibodies/lysates? Have any further splice variants/modified forms been reported?
|
|
Reinigung
|
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
|
|
Buffer
|
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
|
|
Lagerung
|
Aliquot and store at -20°C. Minimize freezing and thawing.
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
|
Publikationen
|
Qi, Yu, Liu et al.: "Septin1, a new interaction partner for human serine/threonine kinase aurora-B." in: Biochemical and biophysical research communications, Vol. 336, Issue 3, pp. 994-1000, 2005 (PubMed).
|
Alternativen zu Antigen "Serologically Defined Breast Cancer Antigen NY-BR-24 (SEPT1)", Typ "Antikörper" finden